CHU Clermont Ferrand
Clermont-Ferrand, Auvergne, 63000, France
NCT Number: NCT04246788
Cerebral palsy is the most frequent motor deficiency in children. Among other, it can leads to spastic diplegia or hemiplegia. Walking abilities is an important skill to the families' point of view in term of independence in curent life. Improving the walking parameters has been the main objective in several studies of rehabilitation. The G-EO system is a last generation robot assisting gait training that can adjust cadence, walk lengh, ankle and hip angles and other walking parameters to movement captation. Its superiority in terms of walking abilities has been demonstrated in adults with stroke sequelae. Only one study was realized in pediatric patients with spastic diplegia with promising results. The investigators hypothesize that intensive robot-assited gait training using the G-EO system in hemiplegic children can improve their walking abilities.
Looking for future studies?
Notify Me4 year–18 year
All sexes
Interventional
Not applicable
Clermont-Ferrand, Auvergne, 63000, France
Objective :
Primary objective: To evaluate walking velocity with the GRAIL (gait real-time analysis and interactive lab) after intensive robot-assisted gait training using the G-EO system in hemiplegic children.
Secondary objectives :Other parameters that will be evaluate include:
Study procedure:
Study evaluation:
T0 : before rehabilitation :
T1 : one month after rehabilitation :
Number of subjects:
Inclusion criteria
Hemiplegic children aged from 4 to 18 years, with a GMFCS (Gross Motor Function Classification System) score between I and III with lower limb involvement. Children must walk alone with or without aid at least 10 meters, must have acquired sitting position, must be able to understand simple orders to follow the rehabilitation program.
Non inclusion criteria:
No lower limb involvement, spasticity = 4 on the modified Ashworth scale, severe cardiorespiratory disease forbidding the rehabilitation program, orthopedic surgery or botulinic toxin injections in the last 6 months before the beginning of the study.
Study calendar:
Statistical analyses Statistical analysis will be performed using Stata 13 software (Stata-Corp, College Station, TX) by an experimented statistician (Bruno Pereira) working in the university hospital of Clermont-Ferrand. A type-I error set at α=0.05 will be considered. Monovariate and multivariate analyses considering age as a covariable will be performed.
Ethical considerations This study has already been presented at the local ethical committee and will be presented in July 2019 at the national " comité de protection des personnes ". Written informed consent from both parents will be collected at the inclusion. This study will be in agreement with the declaration of Helsinki and the current regulations of clinical trials. It will be declared on the internet site "clinicaltrials.gov".
Expected results :
Intensive robot-assisted gait training using the G-EO system may improve the walking abilities in children with infantile hemiplegia and consequently improve their independence and quality of life. Musculo-squeletal parameters and profile of cerebral activated areas involved in praxia may also be modified by this intensive rehabilitation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
5 sessions per week of 30 minutes of robot-assisted rehabilitation with the G-EO system during two weeks
3 sessions per week of 30 minutes of classical physiotherapy during two weeks
Time frame: day 1
gait speed assessed during a gait assessment session using the GRAIL system
Time frame: day 21
gait speed assessed during a gait assessment session using the GRAIL system
Time frame: day 51
gait speed assessed during a gait assessment session using the GRAIL system
Time frame: day 1
endurance evaluation by 6 min. walk test (6-WT)
Time frame: day 21
endurance evaluation by 6 min. walk test (6-WT)
Time frame: day 51
endurance evaluation by 6 min. walk test (6-WT)
Time frame: day 1
Joint amplitudes measured during gait assessment with the GRAIL
Time frame: day 21
Joint amplitudes measured during gait assessment with the GRAIL
Time frame: day 51
Joint amplitudes measured during gait assessment with the GRAIL
Time frame: day 1
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 21
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 51
Number of steps per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 1
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 21
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 51
distance traveled per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 1
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 21
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 51
quality of sleep per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 1
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 21
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 51
heart rate per 24 hours, per 24h, measured using a wristband actimeter which will be given to each child for 24 hours
Time frame: day 1
Evaluation of spasticity by the modified Ashworth scale
Time frame: day 21
Evaluation of spasticity by the modified Ashworth scale
Time frame: day 51
Evaluation of spasticity by the modified Ashworth scale
Time frame: day 1
Overall functional independence assessed with the MIF-Môme autonomy scale
Time frame: day 21
Overall functional independence assessed with the MIF-Môme autonomy scale
Time frame: day 51
Overall functional independence assessed with the MIF-Môme autonomy scale
Time frame: day 1
Overall motor function evaluated with the EMFG
Time frame: day 21
Overall motor function evaluated with the EMFG
Time frame: day 51
Overall motor function evaluated with the EMFG
Time frame: day 1
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Time frame: day 21
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Time frame: day 51
Muscle strength will be measured with a quotation scale (1 to 5) for manual muscle testing
Time frame: day 21
fat body mass
Time frame: day 51
fat body mass
Time frame: day 21
lean body mass
Time frame: day 51
lean body mass
Time frame: day 21
Functional brain connectivity analyzes by functional brain MRI
Time frame: day 51
Functional brain connectivity analyzes by functional brain MRI
University Hospital, Clermont-Ferrand
Other
Acronym: RIPHIGEO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06191588
Bimanual Intensive Therapy, Constraint Induced Movement Therapy
Seville, Spain
View Trial DetailsNCT05226910
Hemiplegia, Infantile Hemiplegia
Toledo, Spain
View Trial DetailsNCT03465046
Hemiplegia, Infantile Hemiplegia
Torrijos, Toledo, Spain
View Trial DetailsNCT04278430
Hemiplegia, Infantile Hemiplegia
View Trial Details